Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CB-300638, a thmidylate synthase inhibitor with potential as an antitumor agent

Aug. 20, 2003

GTI-2040 cleared to enter NCI phase II breast cancer trial in combination with capecitabine

Aug. 19, 2003

SBIR grants support anticancer drug development at Tularik

Aug. 19, 2003

New, potent inhibitors of rat 17alpha-hydroxylase/C17,20-lyase

Aug. 18, 2003

FDA Advisory Committee schedules review of Metvix for basal cell carcinoma

Aug. 13, 2003

Receptor tyrosine kinase inhibitors and their use reported by Theravance

Aug. 13, 2003

Paratek claims non-antibacterial tetracyclines for cancer, stroke and lung injury

Aug. 13, 2003

Phase II trial preparations advance for Norwood Immunology technology

Aug. 13, 2003

Enrollment opens in phase II trial of Tarceva in malignant glioma

Aug. 13, 2003

Sulphamoylated estrogen derivatives show potential in treating drug-resistant breast cancer

Aug. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...